Local methylprednisolone inhibition of foreign body response to coated intracoronary stents

Coronary Artery Disease

Volumn 7, Issue 2, 1996, Pages 161-166

  De Scheerder, Ivan ^a   Wang, Kai ^a   Wilczek, Krzyzstof ^a   Van Dorpe, Joke ^b   Verbeken, Erik ^a   Desmet, Walter ^a   Schacht, Etienne ^b   Piessens, Jan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

corticosteroids; intracoronary stenting; methylprednisolone; restenosis

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; POLYMER; POLYPHOSPHAZENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; FOREIGN BODY REACTION; IMPLANT; NONHUMAN; PRIORITY JOURNAL; STENT; SWINE;

EID: 0030038602     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199602000-00011     Document Type: Article

References (13)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. for the Benestent Study Group: A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. New Engl J Med 1994, 331:489-495.
2. Fishman D, Leon M, Baim D, Schatz R, Savage M, Penn I, et al.: A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. New Engl J Med 1994, 331:496-501.
3. Karas SP, Gravanis MB, Santioian EC, Robinson KA, Andenberg KA, King III SB: Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol 1992. 20:467-74.
4. de Scheerder IK, Wilczek KL, Verbeken EV, Vandorpe J, Lan PN, Schacht E, et al.: Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 1995, 114:105-114.
5. de Scheerder I, Wilczek K, van Dorpe J, Verbeken E, Cathapermal S, Wang K, et al.: Local anglopeptin delivery using coated stents reduces neointimal proliferation in overstretched porcine coronary arteries. Cath Cardiovasc Diagn 1996 (submitted for publication).
6. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: mechansisms of action and clinical considerations. Ann Intern Med 1976, 84:304-315.
7. Crommen J, Vandorpe J, Schacht E: Degradable polyphosphazenes for biomedical applications. J Controlled Release 1993, 24:167-180.
8. Barth K, Eicker B, Bittner U, Marhoff P: The improvement of vessel quantification with Image processing equipment for high resolution digital angiography. In Computer Assisted Radiology. Edited by Lemke HV. Berlin: Springer-Verlag; 1989:220-225.
9. Desmet W, Willems JL, Vrolix M, van Lierde J, Byttebier G, Piessens J: Intra- and interobserver variability of a fast on-line quantitative coronary angiographic system. Int J Cardiac Imaging 1993, 9:249-256.
10. Voss R, Mueller IR, Matthias FR: Effect of monocytopenia on trauma-induced atherosclerotic lesions in the rabbit ear artery Exp Mol Pathol 1988, 49:75-86.
11. Gordon JB, Berk BC, Bettman MA, Selwyn AP, Rennke H, Alexander RW: Vascular smooth muscle proliferation following balloon injury is synergistically inhibited by low molecular weight heparin and hydrocortisone [abstract]. Circulation 1987, 76 (suppl IV):213.
12. Chervu A, Moore WS, Quinones-Baldrich WJ, Henderson T: Efficacy of corticosteroids in suppression of intimal hyperplasia. J Vasc Surg 1989, 10:129-134.
13. Parente L, Fitzgerald MF, Flower RJ, de Nucci G: The effect of glucocorticoids on lyso-PAF formation in vitro and in vivo. Agents Actions 1985, 24:312-313.